Adult congenital pulmonary valve insertion using a new bioprosthetic aortic valve: Inspiris

Do‐Nguyen, Chi Chi; Kilcoyne, Maxwell; Stevens, Randy; Starc, James; Madan, Nandini; Mahan, Vicki; Mesia, Cesar I.; Moulick, Achintya

doi:10.1002/ccr3.2794

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The limited duration of clinical and echocardiographic follow-up notwithstanding, our outcomes compare favorably to those reported in the literature. 15,16 Although there is a dearth of data regarding the durability of the Inspiris Resilia bioprosthesis in the pulmonic position, various retrospective studies have validated its precursor, the Carpentier-Edwards Perimount valve, as a suitable alternative for PVR. Taken together, these studies indicate that stented bioprosthetic valves have become the favored valvular replacement option given optimal rates of survival and freedom from reintervention (Table 2).…”

Section: Commentmentioning

confidence: 99%

See 1 more Smart Citation

Early Outcomes of Pulmonary Valve Replacement With the Edwards Inspiris Resilia Pericardial Bioprosthesis

Sengupta,

Pastuszko,

Zaidi

et al. 2023

World J Pediatr Congenit Heart Surg

View full text Add to dashboard Cite

Background Controversy regarding the optimal pulmonary valve substitute remains, with no approved surgical valve for pulmonary valve replacement (PVR). Furthermore, unfavorable anatomy often precludes transcatheter PVR in patients with congenital heart disease. We therefore sought to evaluate the feasibility of the Edwards Inspiris pericardial aortic bioprosthesis in the pulmonary position in pediatric and adult patients requiring PVR. Methods Data from consecutive patients who underwent PVR from February 2019 to February 2021 at our institution were retrospectively reviewed. Postoperative adverse events included paravalvular or transvalvular leak, endocarditis, explant, thromboembolism, valve thrombosis, valve-related bleeding, hemolysis, and structural valve degeneration. Progression of valve gradients was assessed from discharge to 30 days and one year. Results Of 24 patients with median age of 26 years (interquartile range [IQR]: 17-33; range: 4-60 years), 22 (91.7%) patients had previously undergone tetralogy of Fallot repair and 2 (8.3%) patients had undergone double-outlet right ventricle repair in the neonatal period or infancy. All patients had at least mild right ventricular (RV) dilatation (median RV end-diastolic volume index 161.4, IQR: 152.3-183.5 mL/m2) and at least moderate pulmonary insufficiency (95.8%) or stenosis (8.3%). Median cardiopulmonary bypass and cross-clamp times were 71 (IQR: 63-101) min and 66 (IQR: 60-114) min, respectively. At a median postoperative follow-up of 2.5 years (IQR: 1.4-2.6; range: 1.0-3.0 years), there were no mortalities, valve-related reoperations, or adverse events. Postoperative valve gradients and the severity of pulmonary regurgitation did not change significantly over time. Conclusions At short-term follow-up, the bioprosthesis in this study demonstrated excellent safety and effectiveness for PVR. Further studies with longer follow-up are warranted.

show abstract

Section: Commentmentioning

confidence: 99%

“…The limited duration of clinical and echocardiographic follow-up notwithstanding, our outcomes compare favorably to those reported in the literature. 15,16…”

Section: Commentmentioning

confidence: 99%

Early Outcomes of Pulmonary Valve Replacement With the Edwards Inspiris Resilia Pericardial Bioprosthesis

Sengupta,

Pastuszko,

Zaidi

et al. 2023

World J Pediatr Congenit Heart Surg

View full text Add to dashboard Cite

show abstract

“…In fact, surgical valves, such as the Magna Ease used for both patients can be fractured permitting a larger sized percutaneous ViV 14 . There are also newer surgical pulmonary valves which may be even more suitable for percutaneous ViV 15 …”

Section: Commentmentioning

confidence: 99%

Outcomes 60 years after surgical valvotomy for isolated congenital pulmonary valve stenosis

2021

View full text Add to dashboard Cite

Congenital pulmonary valve stenosis (PVS) is a common congenital heart defect. In the infancy of cardiac surgery, open surgical valvotomy or closed surgical transventricular pulmonary valvotomy (Brock procedure) were the mainstays of therapy. We report the longest‐known published follow‐up of two women who as young children underwent pulmonary valvotomy for PVS and subsequent uncomplicated open pulmonary valve replacement over 60 years later.

show abstract

Use of the Inspiris valve in the native right ventricular outflow tract is associated with early prosthetic regurgitation

Nguyen¹,

Vinogradsky²,

Sevensky³

et al. 2023

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

Adult congenital pulmonary valve insertion using a new bioprosthetic aortic valve: Inspiris

Abstract: We describe successful placement of the Inspiris Resilia aortic valve in the pulmonary position. This valve has advantages for immediate benefit and future percutaneous interventions, making it a promising prosthesis for adult congenital patients.

Cited by 5 publications

References 9 publications

Early Outcomes of Pulmonary Valve Replacement With the Edwards Inspiris Resilia Pericardial Bioprosthesis

Early Outcomes of Pulmonary Valve Replacement With the Edwards Inspiris Resilia Pericardial Bioprosthesis

Outcomes 60 years after surgical valvotomy for isolated congenital pulmonary valve stenosis

Use of the Inspiris valve in the native right ventricular outflow tract is associated with early prosthetic regurgitation

Contact Info

Product

Resources

About